Tag Archives: Stage III

Alternative Treatment Options for Late Stage Lung Cancer Patients

Paclitaxel plus carboplatin(PC) is the current standard regimen for advanced or metastatic non-small-cell lung cancer (NSCLC) patients.  However, paclitaxel is associated with serious toxicity such as peripheral neuropathy. A tria,l published in October version of the Annals of Oncology, was … Continue reading

Posted in Cancer, Lung Cancer | Tagged , , , , , , , , | Comments Off on Alternative Treatment Options for Late Stage Lung Cancer Patients